Home> Regulatory Information

NMPA Announcement on the Cancellation of Registration Certificates for 283 Drugs including Megestrol Acetate Dispersible Tablets

CCFDIE|Updated: 2021-05-24

According to the Regulations for the Implementation of the Drug Administration Law of the People's Republic of China and the Provisions for Drug Registration, NMPA has decided to cancel the registration certificate of 283 drugs including Megestrol Acetate Dispersible Tablets.